BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Total Liabilities
BRAIN Biotech AG
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Total Liabilities
€46m
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Total Liabilities
€4.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evonik Industries AG
XETRA:EVK
|
Total Liabilities
€11B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
Covestro AG
XETRA:1COV
|
Total Liabilities
€7.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Total Liabilities
€263.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Total Liabilities
€4.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
See Also
What is BRAIN Biotech AG's Total Liabilities?
Total Liabilities
46m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Total Liabilities amounts to 46m EUR.
What is BRAIN Biotech AG's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
2%
Over the last year, the Total Liabilities growth was 5%. The average annual Total Liabilities growth rates for BRAIN Biotech AG have been 1% over the past three years , 2% over the past five years .